1st Quarter - Report
IGM BIOSCIENCES, INC. for IGM BIOSCIENCES, INC.
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to supply chain and biopharmaceutical manufacturing FY2024 Defense Appropriations H.R.7085 - BIOSECURE Act S.3558 - A bill to prohibit contracting with certain biotechnology providers, and for other purposes (Senate BIOSECURE Act) H.R.7024 - Tax Relief for American Families and Workers Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW WESLEY WOMACK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.